Sanofi/Regeneron Refocus Kevzara COVID-19 Trial On Critical Patients, Showing Value Of A Proper Trial

 
• By Jessica Merrill

A Phase III trial testing Kevzara in hospitalized COVID-19 patients will continue only with the high dose in more advanced critical patients after the low-dose was unsuccessful.

Inscription COVID-19 on white background. World Health Organization WHO introduced new official name for Coronavirus disease named COVID-19
Kevzara COVID-19 trial is being modified • Source: Shutterstock

More from COVID-19

More from Scrip